Aquisição de LANREOTIDA [120 MG/488 MG; SERINGA], OZANIMOD [0.92 MG; CÁP] e OZANIMOD [(0.23 MG) + (0.46 MG); CÁP] ao abrigo do Acordo Quadro 2022/173

ID 10616671 · Portal BASE
Price
Base Price
€23,845 .00
Effective Price
€8,572 .00 -64.1%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Braga, Braga
Bidder Count
—
Winner
CELGENE, SOCIEDADE UNIPESSOAL LDA
NIF 507791690
Company
Dates
Publication
19 Mar 2024
Celebration
21 Dec 2023
Contracting Entity
Unidade Local de Saúde de Braga, EPE
NIF 515545180
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
19 Mar 2024
Signing Date
21 Dec 2023
Days Late
89
Rule
A2/A3 late publication: 89 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
23845.0
Total effective price
8572.0
Ratio
0.3595
Direction
reduction
Rule
A9 price reduction: ratio 0.3595 outside [0.5, 1.5]
Detected 2026-03-06